“Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations with Various Genetic Variants” (2022) Precision Medicine Communications, 2(1), pp. 59–78. doi:10.55627/pmc.002.001.0053.